Editing Abbott Laboratories (section)

===Organization===
[[File:FreeStyle libre am Oberarm und Auslesegerät-1.JPG|thumb|Abbott's FreeStyle libre]]
Abbott's core businesses focus on diagnostics, medical devices, branded generic medicines and nutritional products, which have been supplemented through acquisitions.

{{As of|2021}}, the firm's divisions are:<ref name=OverviewAbbottOps>{{Cite web |url=https://www.abbott.com/investors/overview.html |title=Overview |website=abbott.com |access-date=2020-04-02 |archive-date=10 March 2020 |archive-url=https://web.archive.org/web/20200310005733/https://www.abbott.com/investors/overview.html |url-status=live }}</ref>
* Nutrition:<ref name=":0" /> [[Infant nutrition|Pediatric nutrition]] (e.g., [[Similac]], Isomil, and Gain), Adult Nutrition (e.g., [[Ensure]] and [[ZonePerfect]]) and special dietary needs (e.g., [[Glucerna]] and [[Juven]])
* Diagnostics:<ref name=":0">{{Cite web|url=http://seekingalpha.com/article/3989906-abbott-laboratories-abt-miles-d-white-q2-2016-results-earnings-call-transcript|title=Abbott Laboratories (ABT) Miles D. White on Q2 2016 Results – Earnings Call Transcript|last=SA Transcripts|date=20 July 2016|publisher=Seeking Alpha|access-date=22 July 2016|archive-date=19 January 2017|archive-url=https://web.archive.org/web/20170119153919/http://seekingalpha.com/article/3989906-abbott-laboratories-abt-miles-d-white-q2-2016-results-earnings-call-transcript|url-status=live}}</ref> core lab, molecular, point of care, rapid diagnostics and Informatics
* Medical devices: rhythm management, electrophysiology, heart failure, structural heart, neuromodulation, diabetes care<ref name="10-K 2021"/>
* Established Pharmaceuticals:<ref name=OverviewAbbottOps/> branded generic drugs sold exclusively in developing markets